Max Robotics — Global Service Robot Directory + US Certification

About

Christopher R. Porter is a leading urologic surgeon and researcher whose work has significantly advanced the field of robotic-assisted prostate cancer surgery. His primary research areas focus on the safety, efficacy, and quality-of-life outcomes of robotic-assisted laparoscopic radical prostatectomy (RALP). Porter’s most impactful contribution is his pioneering analysis of the mechanical failure rate of the da Vinci robotic system, a study that has garnered 69 citations and established a critical benchmark for patient counseling and surgical risk assessment. This work, along with a related study (21 citations), directly informed preoperative protocols and enhanced patient safety. He has also conducted influential randomized trials on postoperative pain management, including the use of belladonna and opium suppositories (17 citations), and investigated the impact of catheter size on patient comfort and continence. More recently, Porter led a landmark prospective study comparing long-term quality-of-life outcomes between open and robotic prostatectomy in a racially diverse, multi-institutional cohort. His research is characterized by a commitment to evidence-based improvements in surgical technique and patient-centered outcomes, making him a respected authority in robotic urologic oncology.